Related Experiment Videos
Looking forward in geriatric anxiety and depression: implications of basic science for the future
Howard K Gershenfeld1, Robert A Philibert, Gary W Boehm
1Departments of Psychiatry and Integrative Biology, University of Texas Southwestern Medical Center/ NC6.530, 5323 Harry Hines Blvd., Dallas, TX 75390-9070, USA. Howard.Gershenfeld@UTSouthwestern.edu
Summary
Genetic strategies and neuroendocrine mechanisms are advancing the understanding of major depression and anxiety etiology. This progress offers new avenues for personalized medicine and improved treatments for psychiatric disorders.
Area of Science:
- Psychiatry
- Genetics
- Neuroendocrinology
Background:
- Major depression and anxiety are prevalent psychiatric conditions with unclear causes.
- Understanding the etiology is crucial for developing effective treatments, especially in geriatric populations.
Purpose of the Study:
- To review advancements in understanding psychiatric illness etiology using genetic strategies.
- To explore the impact of these advancements on geriatric psychiatry.
- To highlight progress in genetic approaches, neuroendocrine mechanisms, and neuroimmune system roles.
Main Methods:
- Review of genetic strategies including linkage, association studies, pharmacogenetics, and gene x environment interactions.
- Examination of thyroid and testosterone mechanisms via nuclear receptors.
- Analysis of the neuroimmune system's role in the stress response.
Main Results:
- Genetic strategies can convert correlational findings into causal pathways.
- Molecular understanding of nuclear receptors provides rationale for targeted hormonal therapies.
- Cytokine pathways are implicated in stress, anxiety, and depressive disorders.
Conclusions:
- Genetic and neuroendocrine research offers promising avenues for treating treatment-refractory psychiatric illnesses.
- Interactions between basic science, drug discovery, and clinical science are vital for patient care.
- Future research in neural-immune interactions may yield novel therapeutic targets.